US › Healthcare

Repligen Corporation (RGEN)

US · Healthcare · Medical Instruments & Supplies

$149.78+1.85%
Last close · 2026-08-04

Latest quarter · ended 2026-06-30

Revenue
$204.1M
Revenue YoY
+11.9%
Net profit
$5.0M
Profit YoY
-66.3%
EPS
$0.54
EPS estimate
$0.45
Net margin
2.5%

EPS came in at 0.54 against a street estimate of 0.45 — a beat of 20.0%.

Key statistics

Market cap
$7.96B
P/E
193.2
Forward P/E
69.0
P/B
3.77
Book value
$37.33
EPS (TTM)
$0.73
52-week high
$175.77
52-week low
$100.99
50-day MA
$133.68
200-day MA
$139.76
Beta
1.06

Analyst view

Analysts rate Repligen Corporation a buy (14 buy, 5 hold, 0 sell out of 19) with an average price target of $182.05.

Shareholding

Insiders
5.24%
Institutions
120.01%

Largest institutional holders

FundStake
BlackRock Inc10.64%
Vanguard Group Inc8.87%
T. Rowe Price Associates, Inc.8.66%
FMR Inc5.13%
United Capital Financial Advisers Inc4.92%
Vanguard Capital Management, LLC4.25%
Vanguard Portfolio Management, LLC4.09%
State Street Corp3.16%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Repligen Corporation — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.